Knowledge Center

Patent / Apr 28, 2022

Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders

Authors:
  • Carla Vozone
  • Mohammad Salman
  • George Magrath
  • Courtney Smith
Source:
US 20220125829

The invention provides methods, compositions, and kits containing a pharmaceutical composition, for treating meibomian gland dysfunction, dry eye disease, and related disorders.

Also in the Knowledge Center

Related Content

·¡±è¾±»å±ð±ôâ„¢

·¡±è¾±»å±ð±ôâ„¢ is an innovative technology with the ability to deliver sustained-release pharmaceuticals via surface erosion resulting in the ability to precisely tune pharmacokinetics to meet the target indication needs.

Page
Read more

Membrane Technology

ËÄÉ«AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

What we do

ËÄÉ«AV is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more